Munich
Germany
28
2014-01-16
27
2013-07-23
These are the the leading inventors for applications assigned to Wilex AG:
Wilex AG based in Munich, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
BINDING EPITOPES FOR G250 ANTIBODY
#2 | 2011-05-26 ✅ Patent 8,492,520 granted on 2013-07-23Binding epitopes for G250 antibody
#3 | 2010-10-21 ✅ Patent 8,492,385 granted on 2013-07-23Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
#4 | 2010-06-29 ✅ Patent 7,745,441 granted on 2010-06-29Urokinase inhibitors
#5 | 2010-01-14 ✅ Patent 8,828,381 granted on 2014-09-09Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
#6 | 2009-11-05 ✅ Patent 9,605,075 granted on 2017-03-28Hybridoma cell line G250 and its use for producing monoclonal antibodies
#7 | 2009-08-13 ✅ Patent 7,951,589 granted on 2011-05-31Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
#8 | 2009-08-13 ✅ Patent 8,461,321 granted on 2013-06-11Nucleic acids encoding a deletion variant of uPAR
#9 | 2009-03-12 ✅ Patent 8,093,258 granted on 2012-01-10Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases
#10 | 2008-10-23 ✅ Patent 7,807,681 granted on 2010-10-05Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
#11 | 2008-08-05 ✅ Patent 7,407,751 granted on 2008-08-05Methods for the detection and prognosis of breast tumors
#12 | 2008-03-11 ✅ Patent 7,342,018 granted on 2008-03-11Urokinase inhibitors and uses thereof
#13 | 2008-03-06 ✅ Patent 7,713,980 granted on 2010-05-11Crystalline modifications of N-α-(2,4,6-triisopropyl-phenylsulfonyl)-3-hydroxyamidino-(L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
#14 | 2008-02-14 ✅ Patent 7,951,943 granted on 2011-05-31Method for preparing and purifying 3-hydroxyamidinophenylalanine compounds
#15 | 2007-09-06 ✅ Patent 7,691,375 granted on 2010-04-06Adjuvant theraphy of G250-expressing tumors
#16 | 2007-03-22 ✅ Patent 7,399,468 granted on 2008-07-15Diagnostic and therapeutic use of antibodies against the urokinase receptor
#17 | 2007-01-02 ✅ Patent 7,157,238 granted on 2007-01-02Diagnostic and therapeutic use of antibodies against the urokinase receptor
#18 | 2006-06-29 ✅ Patent 7,608,623 granted on 2009-10-27Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
#19 | 2006-05-23 ✅ Patent 7,049,460 granted on 2006-05-23Selective inhibitors of the urokinase plasminogen activator
#20 | 2006-05-18 ✅ Patent 7,314,863 granted on 2008-01-01Cyclic peptidomimetic urokinase receptor antagonists
#21 | 2006-05-02 ✅ Patent 7,038,074 granted on 2006-05-02Arginine mimetics as factor Xinhibitors
#22 | 2005-12-01 ✅ Patent 7,538,216 granted on 2009-05-26Guanidino phenylalanin compounds used as urokinase inhibitors
#23 | 2005-11-24 ✅ Patent 7,632,496 granted on 2009-12-15Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas
#24 | 2005-11-03 ✅ Patent 7,247,724 granted on 2007-07-24Method for the production of phenylalanine derivatives
#25 | 2005-09-29 ✅ Patent 7,208,521 granted on 2007-04-24Selective inhibitors of the urokinase plasminogen activator
#26 | 2005-06-14 ✅ Patent 6,906,032 granted on 2005-06-14Cyclic peptidomimetic urokinase receptor antagonists
#27 | 2005-05-12 ✅ Patent 7,045,504 granted on 2006-05-16Cyclic peptidomimetic urokinase receptor antagonists
#28 | 2005-03-29 ✅ Patent 6,872,702 granted on 2005-03-29Inhibitors for urokinase receptor
Also check out WILEX AG's (Munich, Germany) applicant profile with 1 patent applications submitted.
51936 ⎘